Research study Program year 2021 Source: CMS Open Payments

Cip332 NGS

Research payments

$2,210,757

140 payments

Through program year 2021, $2,210,757 in research payments was reported against Cip332 NGS, across 140 payments, paid by Medtronic, Inc..

Paid by: Medtronic, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$2,210,757	140

Breakdown

Who paid Research payments · program year 2021

Medtronic, Inc. $2,210,757 140 payments

Who received the money Research payments · program year 2021

Texas Diabetes & Endocrinology Pa Organisation paid for research $435,820 39 payments
Southeastern Endocrine & Diabetes Pc Organisation paid for research $366,483 14 payments
William Sansum Diabetes Center Organisation paid for research $352,055 12 payments
Diabetes And Glandular Disease Clinic Pa Organisation paid for research $338,629 10 payments
Amcr Institute Organisation paid for research $185,223 5 payments
Iowa Diabetes & Endocrinology Organisation paid for research $169,176 11 payments
Diablo Clinical Research Organisation paid for research $143,857 10 payments
Atlanta Diabetes Associates Organisation paid for research $113,069 4 payments
Pediatric Endocrine Associates PC Organisation paid for research $38,499 22 payments
Gsr Enterprises Inc. Dba Somnos Clin. Organisation paid for research $19,795 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.